Research highlights on kidney transplantation in 2022 from China
10.3969/j.issn.1674-7445.2023.03.003
- VernacularTitle:2022年中国肾移植研究年度盘点
- Author:
Jianchao WEI
1
;
Kaiming HE
;
Qiquan SUN
Author Information
1. Department of Kidney Transplantation, Guangdong Provincial People's Hospital Affiliated to Southern Medical University, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
- Publication Type:Research Article
- Keywords:
Kidney transplantation;
Rejection;
Ischemia-reperfusion injury;
Infection;
Inflammation;
Chronic allograft dysfunction;
Delayed graft function;
Fibrosis
- From:
Organ Transplantation
2023;14(3):336-
- CountryChina
- Language:Chinese
-
Abstract:
As a mature organ transplantation surgery, kidney transplantation has become the best means for treating end-stage renal diseases and improves the quality of survival of patients. However, there are still many challenges after kidney transplantation, such as rejection, infection, ischemia-reperfusion injury and fibrosis of transplant kidney, which seriously affect the efficacy of kidney transplantation. With the development of translational medicine, regenerative medicine, biomaterials and other emerging fields, Chinese research teams continue to work hard and publish many bright researches to solve various clinical problems related to kidney transplantation. This article reviews the basic and clinical frontiers of kidney transplantation in 2022 as well as the new techniques and advances in the field of transplantation, focuses on the achievements made by the Chinese team in the field of transplantation in 2022, and provides ideas for solving the major clinical problems of kidney transplantation from the perspective of localization to promote the further development of kidney transplantation in China.
